Contractors / DMS Pharmaceutical Group Inc

DMS Pharmaceutical Group Inc

prime recipient of federal awards · UEI PX72BSBQTKJ3 ✓ from source

$299.2M

obligated · FY2025

funding agencies

100%

from Defense

single-source

states

96%

in Illinois

industries

≈ computedSingle-source: 0% of this recipient’s $299.2M in federal contracts was awarded without competition (FPDS extent-competed codes); the rest was competed or unclassified. A high share often reflects sole-source or specialized work, not wrongdoing.

Obligations by year

≈ computed

$180.5M

FY20

$241.2M

FY21

$261.6M

FY22

$255.6M

FY23

$260.1M

FY24

$299.2M

FY25

▲ 66%

since FY20

Where this money comes from

✓ from source

FUNDING AGENCIES

DMS PHARMACEUTICAL GROUP

Defense

$0.3B

DMS Pharmaceutical Group Inc

$0.3B

FY2025 obligated

band width = obligations · FY2025 · source: USASpending.gov

Biggest awards (total value)

No awards yet.

What it does (NAICS / PSC)

Drugs and Druggists' Sundries Merchant Wholesalers$279.4M

Medicinal and Botanical Manufacturing$15.2M

Pharmaceutical Preparation Manufacturing$4.3M

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers$212K

Where the work lands

Illinois✓ from source$287.6M

Pennsylvania✓ from source$11.5M

North Carolina✓ from source$18K

New York✓ from source$1.9K

Competitors

Amerisourcebergen Drug Corp≈ computed$2.5B

Mckesson Corporation≈ computed$10.3M

computed from shared NAICS, not a stated rivalry.

Corporate family

Single registration: no combined family.

🔎

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; figures we calculate are ≈ computed; links we infer (corporate parents, districts, competitors, connections between records) are ≈ inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.